Three early-stage cancer drug projects receive pilot grants to help them advance from the bench toward the bedside.

An early clinical trial at U-M finds that a Wee1 inhibitor, combined with radiation and gemcitabine, is safe and potentially effective in pancreatic cancer treatment.

Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.

Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis.

Michigan-led research presents a new way of uncovering predictive biomarkers when data from large randomized trials aren’t available.

When the surgical wound doesn’t heal right, it can send some patients back to the operating room.